Additive Manufacturing Strategies

Biolase and Stratasys Reach 3D Printing Distribution Deal

ST Medical Devices

Share this Article

There is no questions about it, the 3D printing market is growing, spreading its reach to encompass a variety of industries all over the planet. Today, Stratasys and Biolase (NASDAQ: BIOL) have entered a reseller agreement, whereby Biolase will begin reselling Stratasys’ Objet30 Orthodesk printers among some of their other machines.

Biolase is the world’s largest manufacturer and distributor of dental lasers. This agreement will allow them to market and sell Stratasys 3d printers for the use within the dental industry. The key printer in this deal will be biolase-1the Objet30 Orthodesk which allows dentists to fabricate delivery and positioning trays, stone models, surgical guides, orthodontic appliances, models for clear aligners, and retainers.

Federico Pignatelli, Chairman and CEO of Biolase, said today, “We are thrilled to be chosen as the first distributor of Stratasys’ dental 3-D printing products for the in-office, chair-side market. We believe that 3-D printing will be a revolutionary factor in dental restoration in the new digital era of dentistry. By combining high-end digital imaging, first in class laser tissue management, intra-oral scanning, CAD/CAM design, chair-side milling, and 3-D printing, dental offices can accurately and rapidly produce a wide range of restorations and appliances. We believe that Stratasys will be the perfect long-term partner for BIOLASE as more and more dental offices recognize the excellent return on investment a digital office provides, as well as the increased convenience and benefits high-tech products provide their patients.”

The Vice President of Vertical Sales-Americas of Stratasys, Craig Perry, explained why this agreement will benefit both companies,

“Our Objet30 Series is the world’s most versatile desktop 3-D printer. It is compact, affordable, and easy to use. With patented, industry-leading Polyjet 3-D printing technology, it offers all of the advantages of a 3-D printer, in a package just right for a dental office.”

This appears to be a very beneficial agreement for both companies, and shareholders seem to feel this way as well. Both stocks are up on the day, with Biolase trading up 12%, and Stratasys up 1.75% since the open.  Nearly all the major 3D printing stocks in the U.S. are up today as well.

Discuss this recent distribution deal.

Share this Article


Recent News

Apple 3D Printing: Is It Possible to 3D Print an iPhone?

Bioprinting from FluidForm Backed by New Jersey’s Biggest Healthcare Network



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

3D Printing Webinar and Event Roundup: January 16, 2022

We’re back in business this week with plenty of webinars and events, both virtual and in-person, starting with the second edition of the all-female-speaker TIPE 3D Printing conference. There are...

Bioprinting Firm REGEMAT3D Preps for IPO with Crowdfunding Campaign

In 2022, Spanish biotech company REGEMAT 3D will open an equity crowdfunding campaign on Crowdcube to add to the €402,500 ($457,000) raised during its first financing round. The funds will...

3D Printing News Briefs, January 12, 2022: Rebranding, Bioprinting, & More

First up in today’s 3D Printing News Briefs, Particle3D has gone through a rebrand, and a team of researchers developed a way to 3D print and preserve tissues in below-freezing...

India’s Primaeam Solutions Opens 3D Printing Service with Materialise

Primaeam Solutions Pvt Ltd, an additive manufacturing (AM) services has announced the opening of a new, 10,000 sq. ft. service bureau located in the firm’s home city of Chennai, the...


Shop

View our broad assortment of in house and third party products.